CREDIT SUISSE AG/ - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$18,467,000
+569.3%
536,076
+224.7%
0.01%
+450.0%
Q2 2020$2,759,000
+288.0%
165,118
+235.1%
0.00%
+100.0%
Q1 2020$711,000
-62.0%
49,269
-11.8%
0.00%0.0%
Q4 2019$1,869,000
+167.4%
55,872
+67.2%
0.00%0.0%
Q3 2019$699,000
+8.2%
33,418
+7.7%
0.00%0.0%
Q2 2019$646,000
-20.6%
31,033
-14.7%
0.00%0.0%
Q1 2019$814,000
+0.9%
36,401
+8.0%
0.00%0.0%
Q4 2018$807,000
-20.1%
33,715
-8.8%
0.00%0.0%
Q3 2018$1,010,000
-12.9%
36,975
-14.3%
0.00%0.0%
Q2 2018$1,160,000
-40.1%
43,160
-29.1%
0.00%
-50.0%
Q1 2018$1,937,000
+50.5%
60,849
+78.9%
0.00%
+100.0%
Q4 2017$1,287,000
+27.4%
34,019
-16.4%
0.00%0.0%
Q3 2017$1,010,000
+56.6%
40,709
+29.7%
0.00%0.0%
Q2 2017$645,000
-30.2%
31,394
-26.0%
0.00%0.0%
Q1 2017$924,000
+21.6%
42,445
+14.1%
0.00%0.0%
Q4 2016$760,000
+131.0%
37,197
+69.3%
0.00%
Q3 2016$329,000
+97.0%
21,966
+41.9%
0.00%
Q2 2016$167,000
-34.5%
15,479
-17.6%
0.00%
Q1 2016$255,000
-84.7%
18,775
-71.5%
0.00%
-100.0%
Q3 2015$1,669,00065,9240.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,967,900$42,933,00029.35%
TLP GROUP LLC 2,833,285$30,656,00020.86%
Aisling Capital LLC 2,990,000$32,352,0007.64%
Vivo Capital, LLC 763,009$8,256,0002.26%
RA Capital Management 1,292,940$13,990,0001.94%
Foresite Capital Management III, LLC 235,020$2,543,0001.74%
Palo Alto Investors LP 325,599$3,523,0000.27%
Rock Springs Capital Management LP 293,000$3,170,0000.24%
EMERALD MUTUAL FUND ADVISERS TRUST 332,625$3,599,0000.20%
Virtus ETF Advisers LLC 19,501$211,0000.16%
View complete list of AIMMUNE THERAPEUTICS INC shareholders